Md Saddam Nawaz is a dynamic and visionary Pharmaceutical Professional with a profound expertise in shaping, integrating, managing, and elevating Quality Management Systems within the realm of GMP manufacturing and technical processes. With an illustrious career spanning 13 years, he's a passionate advocate for quality systems that govern and enhance lean, efficient, and productive GMP operations. His journey in the pharmaceutical landscape has been marked by a relentless pursuit of excellence and a remarkable ascent in responsibilities and duties. His extensive portfolio encompasses pharmaceutical development, facility concept design, validation and qualification, manufacturing, quality control, documentation, and GMP inspection, allowing him to embrace a panoramic view of manufacturing capabilities and global compliance standards. As the current Site Quality Management Head of ACI HealthCare Limited (AHL) in Bangladesh, he commands a position of pivotal influence within the pharmaceutical industry. AHL stands as a distinguished subsidiary of Advanced Chemical Industries (ACI) Limited, a renowned pharmaceutical giant in Bangladesh. Under his guidance, AHL is poised at the forefront of innovation, manufacturing, and marketing of pharmaceutical products destined for global regulated markets, with a particular focus on the United States. Md Saddam Nawaz's leadership and comprehensive industry knowledge ensure that his contributions transcend boundaries and propel the pharmaceutical sector into new dimensions of excellence and global compliance.

The Pop in Your Job
I firmly believe that the realm of GMP is akin to a sacred calling—a commitment for life. With this unwavering dedication, I am driven to continually expand my knowledge and expertise to better serve the global healthcare and pharmaceutical community.

Imperial Chemical Industries (ICI), a British multinational, originally established a branch in East Pakistan, which later evolved into a company called ICI Bangladesh Manufacturers Limited after the country's liberation. In 1992, ICI divested its investments in Bangladesh, leading to a change in the company's name to Advanced Chemical Industries (ACI) Limited. It was the first company in Bangladesh to obtain ISO 9001 certification in 1995. Today, ACI Limited is one of Bangladesh's leading conglomerates with a strong focus on the pharmaceutical sector. Operating through its 'Health Care Division,' ACI Pharma is committed to enhancing healthcare in Bangladesh. ACI Pharma currently manufactures over 650 dosage forms, spanning a wide range of pharmaceutical products, including cardiovascular, anti-infective, CNS, antidiabetics, antipyretics, vitamins and minerals, antibiotics, NSAIDs, anti-ulcerants, steroids, antispasmodics, antipsychotics, antiemetics, antiseptics, and antiasthmatics, among others. ACI Pharma has expanded its reach over the past two decades, exporting pharmaceutical products to more than 50 countries worldwide, including the United States. With a portfolio of over 400 registered drugs globally, ACI is dedicated to delivering innovative and reliable pharmaceutical solutions to improve healthcare in Bangladesh and beyond.